Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Post by SouthernTierTomon Mar 26, 2021 10:42am
222 Views
Post# 32885787

I would NEVER EVER use "VERY DISAPPOINTING" ....

I would NEVER EVER use "VERY DISAPPOINTING" ....It would appear this is the desired headline...Oh Donnie, it must be tough working this one ; - )

I would request that our CMO has his name immediately removed from the Cytosorbent website as an adviser.  He is the CMO of our firm.... CTSO is an implied "competitor"  

I would request immediate clarification on the "advisory firm" that received the $1.7M, that together with the 171K "goof-up" now increased to a $275K "goof-up" and the curious accounting of the $6.5M gift from Baxter led the amazing year of 2020 to the delivery of 400K options at 46.5 cents CAD and 63 cents CAD for the balance ( duplication of previous year )  It would seem unethical to hand out $1.7M at such an inopportune time and not specifiy the receiver.  Does the Paradigm financing ever happen without such a curious course of accounting events?  My guess is that it would have been darn difficult given all the approvals and tip money flying around.

Nothing on the Covert 19 trial in the MD&A?  what up?

Nice jump from 200K PMX patients to over 300K....nice job by Mr. Takashita et al

Another plus is that our former partner of many years and $10M of financing at 70 cents with NO warrants removed their 3 cent SP target from their website..this is very telling eh David: - )



<< Previous
Bullboard Posts
Next >>